These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Reporting of trials of gabapentin. Gordh TE, Jensen TS, Kalso E. N Engl J Med; 2010 Apr 29; 362(17):1641; author reply 1641-2. PubMed ID: 20427815 [No Abstract] [Full Text] [Related]
5. Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin litigation. Vedula SS, Goldman PS, Rona IJ, Greene TM, Dickersin K. Trials; 2012 Aug 13; 13():136. PubMed ID: 22888801 [Abstract] [Full Text] [Related]
6. Confounding factors in off-label drug use. Greenberg PE, Pike C, Sisitsky T. Health Aff (Millwood); 2012 Feb 13; 31(2):460; author reply 460. PubMed ID: 22323178 [No Abstract] [Full Text] [Related]
7. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. Vedula SS, Bero L, Scherer RW, Dickersin K. N Engl J Med; 2009 Nov 12; 361(20):1963-71. PubMed ID: 19907043 [Abstract] [Full Text] [Related]
8. Diabetic peripheral neuropathic pain: is gabapentin effective? Hyatt JD, Daniel D, Tran QV, Millares M, Kubota DR. Am Fam Physician; 2011 Sep 01; 84(5):480, 482; author reply 482. PubMed ID: 21888297 [No Abstract] [Full Text] [Related]
9. Gabapentin for pain: balancing benefit and harm. Ebell M, Kripke C. Am Fam Physician; 2006 Feb 01; 73(3):435. PubMed ID: 16477890 [No Abstract] [Full Text] [Related]
10. Compromising the medical literature: the hidden influence of industry-biased articles. Fugh-Berman A, Siwek J. Am Fam Physician; 2011 Sep 01; 84(5):489-90. PubMed ID: 21888299 [No Abstract] [Full Text] [Related]
11. Gabapentin and Pregabalin for Pain - Is Increased Prescribing a Cause for Concern? Goodman CW, Brett AS. N Engl J Med; 2017 Aug 03; 377(5):411-414. PubMed ID: 28767350 [No Abstract] [Full Text] [Related]
12. Gabapentin in the operating room: clear for discharge? Markman JD. Neurology; 2006 Oct 10; 67(7):1116-7. PubMed ID: 17030742 [No Abstract] [Full Text] [Related]
13. Gabapentin for Chronic Neuropathic Pain. Moore A, Derry S, Wiffen P. JAMA; 2018 Feb 27; 319(8):818-819. PubMed ID: 29486015 [Abstract] [Full Text] [Related]
14. Evidence, regulation and 'rational' prescribing: the case of gabapentin for neuropathic pain. Ghinea N, Lipworth W, Kerridge I. J Eval Clin Pract; 2015 Feb 27; 21(1):28-33. PubMed ID: 24986307 [Abstract] [Full Text] [Related]
15. Intended and unintended consequences of the gabapentin off-label marketing lawsuit among patients with bipolar disorder. Chace MJ, Zhang F, Fullerton CA, Huskamp HA, Gilden D, Soumerai SB. J Clin Psychiatry; 2012 Nov 27; 73(11):1388-94. PubMed ID: 23146199 [Abstract] [Full Text] [Related]
16. False Claims Act prosecution did not deter off-label drug use in the case of neurontin. Kesselheim AS, Darby D, Studdert DM, Glynn R, Levin R, Avorn J. Health Aff (Millwood); 2011 Dec 27; 30(12):2318-27. PubMed ID: 22147859 [Abstract] [Full Text] [Related]
17. Does acute pain associated with herpes zoster respond to treatment with gabapentin? Moulin D. Nat Clin Pract Neurol; 2006 Jun 27; 2(6):298-9. PubMed ID: 16932569 [No Abstract] [Full Text] [Related]
18. Re: Newer antidepressants and gabapentin for hot flashes: a discussion of trial duration. Guttuso T. Menopause; 2009 Jun 27; 16(6):1228; author reply 1228-9. PubMed ID: 19820415 [No Abstract] [Full Text] [Related]
19. Gabapentin and tinnitus relief. Shulman A. Int Tinnitus J; 2008 Jun 27; 14(1):1-5. PubMed ID: 18616079 [No Abstract] [Full Text] [Related]
20. Brachioradial pruritus: report of a new case responding to gabapentin. Kanitakis J. Eur J Dermatol; 2006 Jun 27; 16(3):311-2. PubMed ID: 16709503 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]